NFKB1 and Sepsis: In conclusion, our study indicates that inhibition of NF-κB for a defined time period after the onset of sepsis using a specific IKK inhibitor (BMS-345541) is beneficial in limiting lung injury without compromising host defense even in the absence of concurrent antibiotic treatment.